Literature DB >> 27372752

In Vitro Activity Assays for MYST Histone Acetyltransferases and Adaptation for High-Throughput Inhibitor Screening.

C E McCullough1, R Marmorstein2.   

Abstract

Lysine acetylation is a posttranslational modification that is carried out by acetyltransferases. The MYST proteins form the largest and most diverse family of acetyltransferases, which regulate gene expression, DNA repair, and cell cycle homeostasis, among other activities, by acetylating both histone and nonhistone proteins. This chapter will describe methods for the preparation and biochemical characterization of MYST family acetyltransferases, including protocols for the preparation of recombinant protein, enzyme assays for measuring steady-state parameters, and binding assays to measure cofactor and inhibitor binding. We also provide details on adapting these assays for high-throughput screening for small molecule MYST inhibitors. This chapter seeks to prepare researchers for some hurdles that they may encounter when studying the MYST proteins so that there may be better opportunity to plan appropriate controls and obtain high-quality data.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bisubstrate kinetics; Enzyme assays; High-throughput screening; Histone acetyltransferases; MYST proteins; Ping-pong mechanism

Mesh:

Substances:

Year:  2016        PMID: 27372752      PMCID: PMC5072368          DOI: 10.1016/bs.mie.2016.01.016

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  31 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  MYST-family histone acetyltransferases: beyond chromatin.

Authors:  Vasileia Sapountzi; Jacques Côté
Journal:  Cell Mol Life Sci       Date:  2010-12-04       Impact factor: 9.261

3.  Small molecule inhibitors of histone acetyltransferase Tip60.

Authors:  Jiang Wu; Juxian Wang; Minyong Li; Yutao Yang; Binghe Wang; Y George Zheng
Journal:  Bioorg Chem       Date:  2010-12-07       Impact factor: 5.275

4.  Statistics and decision making in high-throughput screening.

Authors:  Isabel Coma; Jesus Herranz; Julio Martin
Journal:  Methods Mol Biol       Date:  2009

5.  Chemistry: Chemical con artists foil drug discovery.

Authors:  Jonathan Baell; Michael A Walters
Journal:  Nature       Date:  2014-09-25       Impact factor: 49.962

6.  Acetylation of HIV-1 integrase by p300 regulates viral integration.

Authors:  Anna Cereseto; Lara Manganaro; Maria Ines Gutierrez; Mariaelena Terreni; Antonio Fittipaldi; Marina Lusic; Alessandro Marcello; Mauro Giacca
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

7.  MYST protein acetyltransferase activity requires active site lysine autoacetylation.

Authors:  Hua Yuan; Dorine Rossetto; Hestia Mellert; Weiwei Dang; Madhusudan Srinivasan; Jamel Johnson; Santosh Hodawadekar; Emily C Ding; Kaye Speicher; Nebiyu Abshiru; Rocco Perry; Jiang Wu; Chao Yang; Y George Zheng; David W Speicher; Pierre Thibault; Alain Verreault; F Bradley Johnson; Shelley L Berger; Rolf Sternglanz; Steven B McMahon; Jacques Côté; Ronen Marmorstein
Journal:  EMBO J       Date:  2011-10-21       Impact factor: 11.598

8.  hMOF, a KAT(8) with many lives.

Authors:  Hestia S Mellert; Steven B McMahon
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

Review 9.  MYST opportunities for growth control: yeast genes illuminate human cancer gene functions.

Authors:  A Lafon; C S Chang; E M Scott; S J Jacobson; L Pillus
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

10.  Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation.

Authors:  Xinwei Cao; Thomas C Südhof
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

View more
  2 in total

1.  A MYST family histone acetyltransferase, MoSAS3, is required for development and pathogenicity in the rice blast fungus.

Authors:  Akanksha Dubey; Jongjune Lee; Seomun Kwon; Yong-Hwan Lee; Junhyun Jeon
Journal:  Mol Plant Pathol       Date:  2019-07-30       Impact factor: 5.663

2.  Low Expression of KAT6B May Affect Prognosis in Hepatocellular Carcinoma.

Authors:  Junjie Jiang; Hui-Ju Wang; Xiao-Zhou Mou; Huanqing Zhang; YiZhen Chen; Zhi-Ming Hu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.